Zobrazeno 1 - 2
of 2
pro vyhledávání: '"Ryota Okude"'
Autor:
Eiji Shinozaki, Yoshinori Kagawa, Ryota Okude, Takuma Tone, Yuji Kunitomi, Masayuki Nakashima
Publikováno v:
Journal of Clinical Oncology. 41:44-44
44 Background: Trifluridine/tipiracil (FTD/TPI) and regorafenib (REG) are standard of care for refractory metastatic colorectal cancer (mCRC). Several phase II trials of FTD/TPI plus bevacizumab (BEV) have been conducted, showing promising efficacy w
Autor:
Naohiro Tomita, Jin Teshima, Chihiro Tanaka, Yoshiyuki Sakamoto, Keiichi Takahashi, Tetsuya Kusumoto, Kazuhiro Yoshida, Atsuyuki Maeda, Kenjiro Kotake, Hideo Baba, Narikazu Boku, Junichiro Yamauchi, Naruhito Takenaka, Michio Itabashi, Megumi Ishiguro, Eiji Sunami, Ryota Okude, Michio Okabe, Keisuke Aiba, Kenichi Sugihara, Mitsuyoshi Ota, Satoshi Morita
Publikováno v:
Clinical Colorectal Cancer. 19:22-31.e6
Background The efficacy of S-1 plus oxaliplatin (SOX) as postoperative adjuvant chemotherapy for colon cancer has not been established. This randomized phase III study was designed to verify the superiority of SOX over tegafur-uracil and leucovorin (